JW (Cayman) Therapeutics Co. Ltd (HKG:2126)
Hong Kong · Delayed Price · Currency is HKD 2.250
+0.100 (4.65%)
Aug 27, 2026, 4:08 PM HKT
HKG:2126 Market Cap
HKG:2126 has a market cap or net worth of 872.67 million as of August 27, 2026. Its market cap has decreased by -64.72% in one year.
Market Cap
872.67M
Enterprise Value
604.86M
Revenue
315.65M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.25
ChartMarket Cap Chart
Since November 3, 2020, HKG:2126's market cap has decreased from 8.28B to 872.67M, a decrease of -89.46%. That is a compound annual growth rate of -32.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2026 | 872.67M | -14.29% |
| Dec 31, 2025 | 1.02B | 96.55% |
| Dec 31, 2024 | 518.01M | -42.89% |
| Dec 29, 2023 | 907.01M | -47.90% |
| Dec 30, 2022 | 1.74B | -67.36% |
| Dec 31, 2021 | 5.33B | -47.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Beijing Biostar Pharmaceuticals | 1.28B |
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1.26B |
| CANbridge Pharmaceuticals | 1.18B |
| Cloudbreak Pharma | 1.01B |
| Sunho Biologics | 970.43M |
| Kintor Pharmaceutical | 834.54M |
| 3D Medicines | 750.06M |
| Brii Biosciences | 743.46M |